#bladder-cancer

[ follow ]
#fda-approval
News Center
1 month ago
OMG science

New Biomarker May Predict Treatment Response in Bladder Cancer - News Center

Patients with metastatic urothelial cancer and high NECTIN4 gene expression respond significantly better to enfortumab vedotin treatment. [ more ]
Los Angeles Times
2 months ago
Medicine

FDA approves bladder cancer treatment by Culver City company

FDA approved new bladder cancer treatment Anktiva by ImmunityBio, activating immune response in patients who didn't respond to prior therapies. [ more ]
News Center
1 month ago
OMG science

New Biomarker May Predict Treatment Response in Bladder Cancer - News Center

Patients with metastatic urothelial cancer and high NECTIN4 gene expression respond significantly better to enfortumab vedotin treatment. [ more ]
Los Angeles Times
2 months ago
Medicine

FDA approves bladder cancer treatment by Culver City company

FDA approved new bladder cancer treatment Anktiva by ImmunityBio, activating immune response in patients who didn't respond to prior therapies. [ more ]
morefda-approval
[ Load more ]